FHC
LEGN icon

First Horizon Corporation’s Legend Biotech LEGN Stock Holding History

First Horizon Corporation’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.94K Sell
275
-57
-17% -$1.54K ﹤0.01% 1169
2026
Q1 		$6.01K Buy
332
+83
+33% +$1.58K ﹤0.01% 1135
2025
Q4 		$5.41K Sell
249
-110
-31% -$3.15K ﹤0.01% 1204
2025
Q3 		$11.7K Buy
+359
New +$13.3K ﹤0.01% 1032

Other funds holding LEGN

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return
ELI
Empire Life Investments Toronto, Ontario, Canada $1.79B AUM 38.49% 1-Year Est. Return
IGAM
iA Global Asset Management Quebec, Quebec, Canada $8.42B AUM 47.61% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return

First Horizon Corporation's LEGN Position: Q2 2026 in Review

First Horizon Corporation reduced its Legend Biotech (LEGN) stake by 17% in Q2 2026, selling an estimated $1.54K and leaving 275 shares worth $7.94K. The position accounts for ﹤0.01% of the portfolio, ranked #1169.

First Horizon Corporation first reported a position in LEGN in Q3 2025 and has held it in 4 quarters since. The position peaked at $11.7K in Q3 2025. 44 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • First Horizon Corporation held 275 shares of Legend Biotech worth $7.94K as of Q2 2026.
  • First Horizon Corporation sold 57 Legend Biotech shares in Q2 2026, an estimated $1.54K.
  • Legend Biotech made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2026, its #1169 holding.
  • First Horizon Corporation first reported a position in Legend Biotech in Q3 2025 and has held it in 4 quarters since.
  • First Horizon Corporation's Legend Biotech position peaked at $11.7K in Q3 2025.
  • 44 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.